Future iterations will focus on emphasizing drug pharmacology, mechanisms of action, and physiological effects for MS1 students, while providing opportunities for more comprehensive knowledge integration through the case studies for MS2 students
Comparing Alternatives: For a comprehensive breakdown of how compounded options compare to brand-name Wegovy-including pricing differences, regulatory status, and clinical considerations-see Best Wegovy Alternative 2026: FDA-Registered Telehealth Options Reviewed
GLP-1 dose escalation is quickly becoming a central topic in diabetes care, especially as higher dosing strategies gain traction
It can be acute or chronic and causes symptoms like severe abdominal pain, nausea, vomiting, and fever
Most patients continue seeing progress for 612 months before reaching their goal weight, at which point maintenance dosing can sustain results long-term without continuous dose escalation